Vote Scores

Home / Companies / Paratek Pharmaceuticals, Inc. / 6 Jul 2023

Meeting · year to 30 June 202482 filers reporting

Paratek Pharmaceuticals, Inc.: meeting of 6 Jul 2023

Votes reported on Form N-PX, item by item

82 Form N-PX filers reported votes at the Paratek Pharmaceuticals, Inc. meeting of 6 Jul 2023. Their records fall into 7 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

3 nominees; 84.3% of reported votes for; 8 filers withheld from or voted against at least one nominee.

102 vote records from 29 filers. 4 of the 29 filers that marked the item either way voted against management.

86.2% for0.0% against13.8% other13.8% against management29 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

92 vote records from 76 filers. 19 of the 75 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided

72.4% for25.0% against2.6% other25.3% against management76 filers81.2% for18.8% against18.8% against management13,944,365 reported shares
3

SECTION 14A SAY-ON-PAY VOTESIssuer

Frequency of the say-on-pay vote

one year: 72 filers; abstain: 4 filers; two years: 1 filer; : 1 filer; three years: 1 filer; not applicable: 1 filer.

95 vote records from 80 filers. 6 of the 78 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

One filer reported a share count too large to be the holding described. That figure is left out of the share split below; the count of filers includes it. How that is decided

0.0% for0.0% against100.0% other7.7% against management80 filers0.0% for0.0% against100.0% other18.2% against management12,684,803 reported shares
4

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

34 vote records from 29 filers. 0 of the 29 filers that marked the item either way voted against management.

100.0% for0.0% against0.0% against management29 filers100.0% for0.0% against0.0% against management8,051,997 reported shares
5

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

9 vote records from 9 filers. 4 of the 9 filers that marked the item either way voted against management.

55.6% for44.4% against44.4% against management9 filers59.1% for40.9% against40.9% against management5,557,778 reported shares, counted once per item in this group
6

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

30 vote records from 21 filers. 1 of the 21 filers that marked the item either way voted against management.

95.2% for4.8% against4.8% against management21 filers100.0% for0.0% against0.0% against management2,590,319 reported shares, counted once per item in this group
7

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

33 vote records from 28 filers. 8 of the 28 filers that marked the item either way voted against management.

71.4% for28.6% against28.6% against management28 filers53.2% for46.8% against46.8% against management8,019,997 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Pay-vote frequency4. Auditor
VanguardForForSplit or no voteFor
BlackRock and iSharesForForSplit or no voteFor
FidelityForForSplit or no voteFor
State Street and SPDRNo reportForSplit or no voteNo report
InvescoForAgainst *Split or no voteFor
EquitableForForSplit or no voteFor
Charles SchwabForForSplit or no voteFor
John Hancock and ManulifeForForSplit or no voteFor
Morgan Stanley, Eaton Vance and CalvertNo reportAgainst *Split or no voteNo report
Goldman SachsNo reportForSplit or no voteNo report
PGIM and PrudentialNo reportAgainst *Split or no voteNo report
Northern Trust and FlexSharesForForSplit or no voteFor
SEINo reportAgainst *Split or no voteNo report
Victory CapitalForForSplit or no voteFor
Guggenheim and RydexForForSplit or no voteFor
BNY MellonNo reportAgainst *Split or no voteNo report
BairdNo reportForSplit or no voteNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Paratek Pharmaceuticals, Inc. meeting?

82 Form N-PX filers reported votes at the meeting of 6 Jul 2023. On say-on-pay, 19 of 75 voted against management (25.3%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Paratek Pharmaceuticals, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Paratek Pharmaceuticals, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Paratek Pharmaceuticals, Inc. with a meeting date within three days of 6 Jul 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 30 Sep 2026.